Psoriasis داء الصدفية.

Slides:



Advertisements
Similar presentations
PITYRIASIS RUBRA PILARIS (PRP)
Advertisements

Epidemiology, presentation, complication and management.
IDENTIFICATION AND MANAGEMENT
Ramesh Mehay Programme Director (Bradford VTS)
Psoriasis. Definition Chronic plaque psoriasis (psoriasis vulgaris) is a chronic inflammatory skin disease characterised by well demarcated erythematous.
Psoriasis. Definition Psoriasis is a common, chronic, disfiguring, inflammatory and proliferative condition of the skin; in which both genetic and environmental.
Psoriasis By Sandra E. Valenzuela 5/5/02 Definition A Chronic (long lasting) skin disease characterized by scaling and inflammation. Scaling occurs when.
May 24, You just attended the delivery of the infant shown. The parents want to know what is wrong with his skin. What condition is most commonly.
Psoriasis Definition: is a chronic, sometimes acute, non- contagious common condition of the skin Definition: is a chronic, sometimes acute, non- contagious.
Psoriatic Arthritis Maggie Davis Hovda Am report 2/16/2010.
Dermatology: Skin cancer & Psoriasis S.L.I.M.E. Workshop Dr Rochelle Velho Academic Foundation Year 1.
Psoriasis & Skin Cancer
Psoriasis. Definition and causes Definition and causes Types Types GP management GP management Pitfalls Pitfalls Hospital treatments Hospital treatments.
PSORIASIS. Psoriasis is a disease which affects the skin and joints. Psoriasis is a disease which affects the skin and joints.skinjointsskinjoints It.
Psoriasis and Skin Cancer Edward Pritchard. Long Cases You could get these! Last year’s finals! - Patient with recurrent SCC, with no symptoms. History.
Papulosquamous diseases Dr. Fahad AlSaif Consultant & Associated Professor Chairman of Dermatology Department.
Psoriasis By Anna Hodge Objectives Recognise psoriasis Know the first line treatments for psoriasis Use topical corticosteroids safely Know.
Psoriasis داء الصدف.
Psoriasis By: Angie Vasquez and Marsa Eglip. Introduction Basic description of psoriasis Basic description of psoriasis Symptoms Symptoms Genetic cause.
SHRI GANASAYA NAMAHA. AN UPDATE ON PSORIASIS BY DR. MAHESH MATHUR, MD,DVD,DCP (UK) MD,DVD,DCP (UK)
Plaque Psoriasis By: Alexis Edwards 6 th. Description Plaque psoriasis is a skin condition in which chronic autoimmune appears on the skin. Psoriasis.
Psoriasis. Definition and causes Types GP management Pitfalls Hospital treatments Case studies.
Psoriasis. Definition l Psoriasis is a recurrent,chronic,inflammatory disease of the skin characterized by red papules or plaques covered by silvery white.
A Red Scaly Rash Small Group Teaching Problem Based Learning Dermatology Department College of Medicine King Saud University.
Alexandra Pyle Bsc (Hons) Registered Nurse. What is Psoriasis?  Psoriasis is a chronic inflammatory skin disorder characterised by thickened, scaly plaques.
Psoriasis. Definition and causes Types GP management Pitfalls Hospital treatments.
 exact cause unknown  defect of the skin that impairs its function as a barrier, combined with an abnormal function of the immune system, are believed.
PSORIASIS Ben Basger Basgers Pharmacy North Bondi Pharmacy Practice, The University of Sydney.
Psoriasis and Other Papulosquamous Disease. Definitions – Psoriasis is the most common chronic papulosquamous disease – The classic lesion of psoriasis.
Pharmacology-4 PHL 425 Fourth Lecture By Abdelkader Ashour, Ph.D. Phone:
Show your Best III By: Brad Moatz MSIV. Presentation 42 y.o. male presents with R foot pain and h/o psoriasis.
Skin Pathology, Case 4 A 25-year-old male presents to his dermatologist with well-demarcated, scaly, pink to salmon-colored plaques over the elbows. Areas.
Eczema & Psoriasis Dr. Jerald E. Hurdle Kennebec Medical Consultants Waterville, ME
Psoriasis. What is psoriasis?  Psoriasis is a non-contagious genetic disease caused by the immune system which effects the skin and joints.  In plaque.
1 Psoriasis. 2 Types of Psoriasis n Nearly 90% of people with psoriasis have plaque-type psoriasis n Less than 10% of people with psoriasis have guttate.
TRIGGER  Ali is a 50-year-old engineer who presented to Dr. Khalid with itching all over his body for the last few weeks. Recently he has noticed that.
PSORIASIS BY: Jennifer Teen Health 8 Old Orchard Junior High School.
بسم الله الرحمن الرحيم.
Psoriasis Victoria Lund. Overview Causes skin cells to mature in less than a week (normally it takes days) The immune system send signals to increase.
Psoriasis disease psoriasis  Content  Definition  Name of the causing bacteria  Common types of psoriasis  Diagnosis  causes.
Psoriasis and Other Papulosquamous Disease
Diagnosis and Management of Psoriasis and Psoriatic Arthritis
Psoriasis د. هدف عبدالامير حسن.
How can pharmacists help improve outcomes for patients with psoriasis?
Psoriasis.
By AFSAR FATHIMA Dept. of Pharmacology
Presentation topic Psoriasis Disease
Diagnosis and treatment algorithm for psoriasis
Psoriasis John Sugrue.
Diseases/Disorders of the Integumentary System
Diseases/Disorders of the Integumentary System
Dr. Qassim Al-chalabi M.B.Ch.B F.A.B.H.S (Dermatology & Venereology)
Department of Dermatology
Psoriatic arthritis (PsA) Introduction
Psoriasis Tutoring By Alaina darby.
A Red Scaly Rash ..
PBL – Papulosquamous Diseases
Psoriasis and Skin Cancer
July 19,2010 by DR M.EJAZ BANGASH SR.INSTRUCTOR FAMILY MEDICINE
Diseases/Disorders of the Integumentary System
Dermatology update in common cases and treatment
Dr Sarah Levy Consultant Rheumatologist CUH
Clive Tubb CNS Dermatology
Kate Blake Lead Nurse Dermatology
Psoriasis By P.Ashwini.
Presentation transcript:

Psoriasis داء الصدفية

Definition :common,chronic,disfiguring, inflammatory and proliferative condition of the skin. -population prevalence varies between 0.3%-3%.considerable racial variation. Age of onset: -has bimodal distribution of age of onset; early peak between 16 &22,and the later one at 57-60 years.

Aetiology : 1-Genetic epidemiology: - The risk for a child to develop psoriasis is 14% if one parent is affected.41% if two parents are affected. & 6%if one sibling is affected. Compared to 2% when no parent or sibling Is affected. heridetary,strongly HLA associated (HLA_Cw6).

2-Environmental risk factors: A-trauma : Trauma to the skin can precipitete ps. In traumatized skin , called koebner phenomenon. B-infection: streptococcal infection has important role ,esp. in guttate psoriasis. C-Drugs: lithium salts, anti- malarials ,β- blockers, NSAID,ACE inhibitors. D-sunlight; generally beneficial ,but strong light may be a provoking factor. E-metabolic factors :hypocalcaemia ppt. ps. f-Psychogenic factors :it is believed to play imprtant role in ps. g:hormonal factors : frequently imprives in pregnency only to relapse postpartum.

-epidermal lymphocyte&neutrophile Pathosenesis : There is a rapid turnover of basal layer to stratum corneum. Normally transit time of proliferation is about 30-60 day but in ps. It reduced to 3 day,the basal cell will retain their nuclei in cornified layer ( parakeratosis ) Pathology : -parakeratosis -acanthosis :irregular thickening of Epidermis. -no granular layer -epidermal lymphocyte&neutrophile Infiltrate (micro-abscesses) -dilated &tortuous capillary loops in Dermal papillae. -

Koebner phenomenon : in psoriasis Also occurs in lichin planus – erythema multiforme –vitiligo –viral wart Auspitz sign :bleeding occur when scale is scratched off.

Clinical feature : Ps varies in severity from chronic stable ps to life threatening (like acute generalized pustular ps or erythrodernic ps ) Ps is characterized by a base of erythrodermic plaques covered by silvery scales mainly on the extensor surface on elbows & knees .

-clinical variets : 1-plaque ps ( ps vulgaris ): plaque ,red (salmon pink) colour,well define edge. Scale, Very characteristic is silvery white scales varying in thickness. Plaques are of variable sizes and shapes. And number, may be symmetrically distribution.

2-guttate ps : acute symmetrical ,mostly seen in adolescent ,may follow streptococcal tonsilitis. 3- flexural ps : affect axilla ,submammary, groin. The plaque are red smooth ,non scally & glazed.

4-Pustular ps: -localized pustular ps : usually palmoplantar pustulosis with haemorrhagic crust &scale involving the instep & palm usu. Seen in smokers. -generalized pustular : it is life threatening ,acute generalized erythroderma studded with pustules.

5-erythrodermic ps :life threatening condition ,in which the body is red ,>90% of body surface area, less scaly 6-psoriatic arthropathy : 5% of the patients have ps arthritis -distal terminal interphalangeal joints of hand &feet -RA like arthritis ( polyarthropathy) -AS like arthritis :(spine involve &sacroilitis) -arthritis mutilans :severe involvement of hands with deformity.

7-nail ps. : 50 % -onycholysis :seperation of distal edge of nail from bed. -pitting (common) -oil spots -subungual hyperkeratosis -splinter hg. -dystrophy

8-scalp ps : the scalp is often involved. Prognosis : Unpredictable in general. Intractable disease but rarely dangerous to life. Guttate attacks have better prognosis Pustular and erythrodermic carry appreciable mortality Psoriatic arthropathy forms considerable morbidity. Early onset and family history worsen prognosis. Complete remissions over 1-54 years were reported in 39% of patients.

Management: 1-general measure :social support ,eradication of infection &treatment of precipating factors . 2-therapeutic measures: a-topical : -topical steroids: moderate to potent e.g. flucinolone,flumetasome, betamethasone.we should avoid very potent steroid e.g. clobetasol because it may cause rebound severe reaction. -keratolytics :e.g salicylic acid 3% to remove the scale . -crude coal tar: smelly ,messy & stain clothes -calcipitriol (vit D3 derivative ):for mild to moderate ps. Affecting less than 40% of the skin. b-phototherapy: (PUVA & UVB ): the equipment should be serviced & calibrated regularly by trained personnel.

C-systemic : 1-retinoids (vit A derivative ) : Acitretin is effectinve in plaque & palmoplantar ps. S.E : -teratogenic : in female should not concept for at least 2year after stoppage of drug. -dryness of skin & mucous mem. -hyperlipdemia 2-methotrexate : for severe ps. ,it has anti-inflammatory &immune modulatory effects , given once weekly (oral or I.M ).improvement is seen in 2-4 weeks. liver function test ,CBP should be monitered . drug interaction with asprin ,NSAID , CO-Trimaxazole. S.E : nausea, vomiting ,hepatotoxicity ,teratogenicty & pulmonary fibrosis.

3-cyclosporin : is immunosoppresant ,effective in sever ps 3-cyclosporin : is immunosoppresant ,effective in sever ps. Act by inhibiting T-lymphocyte activities .hypertention is common S.E. ,nephrotoxic (dose dependant) 4-Biological drugs : e.g Infliximab , Etanercept..etc very effective & safe but very expensive.